Atrioventricular block-induced Torsades de Pointes with clinical and molecular backgrounds similar to congenital long QT syndrome

Circ J. 2010 Nov;74(12):2562-71. doi: 10.1253/circj.cj-10-0498. Epub 2010 Oct 21.

Abstract

Background: Atrioventricular block (AVB) sometimes complicates QT prolongation and torsades de pointes (TdP).

Methods and results: The clinical and genetic background of 14 AVB patients (57±21 years, 13 females) who developed QT prolongation and TdP was analyzed. Electrophysiological characteristics of mutations were analyzed using heterologous expression in Chinese hamster ovary cells, together with computer simulation models. Every patient received a pacemaker or implantable cardioverter defibrillator; 3 patients had recurrence of TdP during follow-up because of pacing failure. Among the ECG parameters, QTc interval was prolonged to 561±76ms in the presence of AVB, but shortened to 495±42ms in the absence of AVB. Genetic screening for KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 revealed four heterozygous missense mutations of KCNQ1 or KCNH2 in 4 patients (28.6%). Functional analyses showed that all mutations had loss of functions and various gating dysfunctions of I(Ks) or I(Kr). Finally, action potential simulation based on the Luo-Rudy model demonstrated that most mutant channels induced bradycardia-related early afterdepolarizations.

Conclusions: Incidental AVB, as a trigger of TdP, can manifest as clinical phenotypes of long QT syndrome (LQTS), and that some patients with AVB-induced TdP share a genetic background with those with congenital LQTS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Animals
  • Atrioventricular Block / complications
  • Atrioventricular Block / genetics*
  • Atrioventricular Block / metabolism
  • Atrioventricular Block / physiopathology*
  • CHO Cells
  • Cohort Studies
  • Computer Simulation
  • Cricetinae
  • Cricetulus
  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels / genetics
  • Ether-A-Go-Go Potassium Channels / metabolism
  • Female
  • Humans
  • Ion Channel Gating / genetics
  • KCNQ1 Potassium Channel / genetics
  • KCNQ1 Potassium Channel / metabolism
  • Long QT Syndrome / genetics*
  • Long QT Syndrome / metabolism
  • Long QT Syndrome / physiopathology*
  • Male
  • Middle Aged
  • Mutation, Missense*
  • Torsades de Pointes / etiology
  • Torsades de Pointes / genetics*
  • Torsades de Pointes / metabolism
  • Torsades de Pointes / physiopathology*

Substances

  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels
  • KCNH2 protein, human
  • KCNQ1 Potassium Channel
  • KCNQ1 protein, human